Data Sharing and Analytics for Oncology Research Launched
Project Data Sphere, an independent not-for-profit initiative, has launched a data sharing platform
Project Data Sphere (PDS), an independent not-for-profit initiative has launched a data sharing platform that has been specifically designed to provide one place where the cancer community can broadly share, integrate and analyze historical patient level, comparator arm data from academic and industry phase III cancer clinical trials. The initiative addressed prior obstacles to clinical trial data sharing by working with leading legal and privacy experts, as well as clinicians, commercial institutions and patient representatives to build an optimal framework to share data responsibly.
Initial data sets of de-identified, patient level data, have been provided by AstraZeneca, Bayer, Celgene, Janssen Research and Development, an affiliate of Johnson & Johnson, Memorial Sloan Kettering Cancer Center, Pfizer, and Sanofi US. PDS is currently working with these and other organizations, including the Alliance for Clinical Trials in Oncology (sponsored by the National Cancer Institute), Amgen, and Quintiles to provide additional cancer data sets.
The Project Data Sphere platform was developed by SAS, an industry leader in data security and analytics. State of the art analytic tools are available on demand to registered users within the platform.
Read the full release here.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
